BCYC

Bicycle Therapeutics plc

Contracts

Total Value

Stock Metrics

0.0%

Short % Float

9.9d to cover · Moderate squeeze

70.5%

Inst % Float

10 holders · 2026-06-30

Baker Bros. Adviso

Top Holder

21.5% of float

26/100

Dilution Score

Medium

25 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

26/100

MEDIUM

Inst: 70.5% · Top: Baker Bros. Advisors, LP

Biotech Analytics

Oncology

5.59

Squeeze risk: MODERATEBiotech Grade: F

Insider Buying0

Publications100

Dilution Risk26

Clinical Trials0

Short Interest10